Vorapaxar and Carbamazepine Interaction

Drug interaction information between Vorapaxar and Carbamazepine.

Vorapaxar and Carbamazepine have a documented moderate interaction in FDA labeling.

FDA drug labeling documents a moderate-severity interaction between Vorapaxar and Carbamazepine. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Vorapaxar

PAR-1 Antagonist (Antiplatelet)

Drug B

Carbamazepine

Anticonvulsant

How They Interact

Carbamazepine speeds up how fast your body gets rid of vorapaxar, which can make the drug less effective.

FDA Label Information

Strong CYP3A Inducers Avoid concomitant use of ZONTIVITY with strong inducers of CYP3A (e.g., rifampin, carbamazepine, St.

Vorapaxar Also Interacts With

View all Vorapaxar interactions →

Frequently Asked Questions

What SPL severity band is on file for Vorapaxar + Carbamazepine?

Compiled FDA labeling labels this pair moderate. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Carbamazepine has 129 labeled pairs on file vs Vorapaxar's 8. In the moderate band specifically: Vorapaxar has 7 (also Ketoconazole, Clarithromycin, Rifampin, Posaconazole); Carbamazepine has 16 (also Lithium, Apixaban, Desmopressin, Dronedarone).

What mechanism field is on file for Vorapaxar and Carbamazepine?

Carbamazepine speeds up how fast your body gets rid of vorapaxar, which can make the drug less effective.

Carbamazepine carries more major-labeled pairs than Vorapaxar

SPL source-record counts only. This page's band is moderate · classes on file: Vorapaxar (PAR-1 Antagonist (Antiplatelet)); Carbamazepine (Anticonvulsant).

Carbamazepine has 3 major-labeled pairs vs Vorapaxar's 0. This page itself is in the moderate band, not the major band.

Vorapaxar

0 major · 7 moderate · 1 minor · 8 total

Carbamazepine

3 major · 16 moderate · 110 minor · 129 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.